Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/19260
Title: | Simvastatin impairs the induction of pulmonary fibrosis caused by a western style diet: a preliminary study. | Austin Authors: | Kruzliak, Peter;Hare, David L ;Zvonicek, Vaclav;Klimas, Jan;Zulli, Anthony | Affiliation: | Centre for Chronic Disease Prevention & Management (CCDPM), Western CHRE, College of Health and Biomedicine, Victoria University, St Albans, Victoria, Australia Department of Anesthesiology and Intensive Care Medicine, St. Anne's University Hospital and Masaryk University, Brno, Czech Republic Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia International Clinical Research Center, St. Anne's University Hospital and Masaryk University, Brno, Czech Republic Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia |
Issue Date: | Nov-2015 | Date: | 2015-08-25 | Publication information: | Journal of cellular and molecular medicine 2015; 19(11): 2647-54 | Abstract: | The role of an atherogenic diet in causing pulmonary fibrosis has received little attention and simvastatin has been shown to reduce pulmonary fibrosis in animal models. To determine if an atherogenic diet can induce pulmonary fibrosis and whether simvastatin treatment is beneficial by up-regulating heat shock protein 70 and 90. New Zealand white rabbits (n = 15) were divided: Group 1 (control); Group 2 (MC) received a normal rabbit diet with 1% methionine plus 0.5% cholesterol (atherogenic diet). Group 3 received the same diet as the MC group plus 5 mg/kg/day simvastatin orally (MCS). After 4 weeks, the lungs were collected and analysed. Picrosirus red staining of lung interstitial collagen content showed that the atherogenic diet increased fibrosis 2.9-fold (P < 0.05), bronchiole adventitial collagen was increased 2.3-fold (P < 0.05) and bronchiole epithelium was increased 34-fold (P < 0.05), and simvastatin treatment severely reduced this effect (P < 0.05). Western blot analysis showed that the atherogenic diet significantly reduced lung Hsp70 protein by 22% (P < 0.05) and Hsp90 protein by 18% (P < 0.05) and simvastatin treatment did not affect this result. However, aortic hyper-responsiveness to vasoconstrictors (angiotensin II and phenylephrine) were markedly reduced by simvastatin treatment. We report that an atherogenic diet stimulates pulmonary fibrosis and reduces lung Hsp70/Hsp90 protein concentration. Simvastatin impairs this by mechanisms unrelated to Hsp70/Hsp90, but possibly a reduction in angiotensin II receptor or alpha adrenergic receptor pathways. These results could have implications in idiopathic pulmonary fibrosis. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/19260 | DOI: | 10.1111/jcmm.12637 | ORCID: | 0000-0001-9554-6556 | Journal: | Journal of cellular and molecular medicine | PubMed URL: | 26304628 | Type: | Journal Article | Subjects: | Hsp70 Hsp90 cholesterol diet fibrosis methionine simvastatin |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.